No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs552148409 |
chr2:209054311-209054312 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs138976184 |
chr2:209054312-209054313 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs142879950 |
chr2:209054317-209054318 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs551009318 |
chr2:209054405-209054406 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs6705133 |
chr2:209054422-209054423 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs530216207 |
chr2:209054449-209054450 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs546737407 |
chr2:209054483-209054484 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs565909928 |
chr2:209054494-209054495 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs534517257 |
chr2:209054500-209054501 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs557659592 |
chr2:209054511-209054512 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs573370126 |
chr2:209054536-209054537 |
Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs571194378 |
chr2:209054603-209054604 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs536918234 |
chr2:209054621-209054622 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs556540283 |
chr2:209054622-209054623 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs573513721 |
chr2:209054628-209054629 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs542744539 |
chr2:209054640-209054641 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs552788694 |
chr2:209054661-209054662 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs115273860 |
chr2:209054671-209054672 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs545601261 |
chr2:209054672-209054673 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs184195068 |
chr2:209054682-209054683 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs531254120 |
chr2:209054704-209054705 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs370488858 |
chr2:209054814-209054815 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs147254062 |
chr2:209054838-209054839 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs186729602 |
chr2:209054842-209054843 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs138699691 |
chr2:209054849-209054850 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs13430046 |
chr2:209054928-209054929 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
27 |
rs566833367 |
chr2:209054944-209054945 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs116533905 |
chr2:209055000-209055001 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs551179088 |
chr2:209055075-209055076 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs571060439 |
chr2:209055076-209055077 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs190830913 |
chr2:209055098-209055099 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs67989853 |
chr2:209055164-209055165 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
33 |
rs571193254 |
chr2:209055180-209055181 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs149342791 |
chr2:209055201-209055202 |
Weak transcription Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs535850180 |
chr2:209055247-209055248 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs10932246 |
chr2:209055323-209055324 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs572866180 |
chr2:209055324-209055325 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs34029379 |
chr2:209055392-209055393 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs559198624 |
chr2:209055400-209055401 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs376893042 |
chr2:209055425-209055426 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs370503632 |
chr2:209055448-209055449 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs34082227 |
chr2:209055449-209055450 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs182515438 |
chr2:209055460-209055461 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs530138315 |
chr2:209055493-209055494 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs540253203 |
chr2:209055496-209055497 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs187226540 |
chr2:209055574-209055575 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs9646836 |
chr2:209055610-209055611 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
48 |
rs556734259 |
chr2:209055655-209055656 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs532471453 |
chr2:209055668-209055669 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs576617441 |
chr2:209055683-209055684 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|